{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T05:56:44Z","timestamp":1738130204190,"version":"3.33.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,28]]},"DOI":"10.7759\/cureus.78143","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T20:49:32Z","timestamp":1738097372000},"source":"Crossref","is-referenced-by-count":0,"title":["Chest Pain as a Symptom of Early-Onset Metastatic Prostate Cancer: Exploring the Role of Screening"],"prefix":"10.7759","author":[{"given":"Fizza","family":"Mohsin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent","family":"Boodhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aarti","family":"Maharaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nissim","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Hashim","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Sajid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaurya","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.8447","article-title":"An unusual presentation of metastatic prostate cancer in a 44-year-old man: a case report and review of the literature","volume":"12","author":"Taheri H","year":"2024","unstructured":"Taheri H, Ebrahimi P, Nazari P, Kefayat A, Mahdavian A. An unusual presentation of metastatic prostate cancer in a 44-year-old man: a case report and review of the literature. Clin Case Rep. 2024, 12:e8447. 10.1002\/ccr3.8447","journal-title":"Clin Case Rep"},{"key":"ref2","unstructured":"Cancer stat facts. prostate cancer. (2018). https:\/\/seer.cancer.gov\/ stat facts\/html\/prost.html."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1822","article-title":"Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations","volume":"15","author":"Agalliu I","year":"2009","unstructured":"Agalliu I, Gern R, Leanza S, Burk RD. Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations. Clin Cancer Res. 2009, 15:1112-20. 10.1158\/1078-0432.CCR-08-1822","journal-title":"Clin Cancer Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-020-00314-z","article-title":"Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2-ERG fusions","volume":"24","author":"Chalmers ZR","year":"2021","unstructured":"Chalmers ZR, Burns MC, Ebot EM, Frampton GM, Ross JS, Hussain MH, Abdulkadir SA. Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2-ERG fusions. Prostate Cancer Prostatic Dis. 2021, 24:558-66. 10.1038\/s41391-020-00314-z","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/pros.21414","article-title":"Early onset prostate cancer has a significant genetic component","volume":"72","author":"Lange EM","year":"2012","unstructured":"Lange EM, Salinas CA, Zuhlke KA, et al.. Early onset prostate cancer has a significant genetic component. Prostate. 2012, 72:147-56. 10.1002\/pros.21414","journal-title":"Prostate"},{"key":"ref6","article-title":"Gleason score","author":"Munjal A","year":"2025","unstructured":"Munjal A, Leslie SW. Gleason score. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000528","article-title":"Ra-223 treatment for bone metastases in castrate-resistant prostate cancer: practical management issues for patient selection","volume":"42","author":"Den RB","year":"2019","unstructured":"Den RB, George D, Pieczonka C, McNamara M. Ra-223 treatment for bone metastases in castrate-resistant prostate cancer: practical management issues for patient selection. Am J Clin Oncol. 2019, 42:399-406. 10.1097\/COC.0000000000000528","journal-title":"Am J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.7307","article-title":"Germline and somatic mutations in prostate cancer for the clinician","volume":"17","author":"Cheng HH","year":"2019","unstructured":"Cheng HH, Sokolova AO, Schaeffer EM, Small EJ, Higano CS. Germline and somatic mutations in prostate cancer for the clinician. J Natl Compr Canc Netw. 2019, 17:515-21. 10.6004\/jnccn.2019.7307","journal-title":"J Natl Compr Canc Netw"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14163888","article-title":"BRCA mutations in ovarian and prostate cancer: bench to bedside","volume":"14","author":"Boussios S","year":"2022","unstructured":"Boussios S, Rassy E, Moschetta M, et al.. BRCA mutations in ovarian and prostate cancer: bench to bedside. Cancers (Basel). 2022, 14:3888. 10.3390\/cancers14163888","journal-title":"Cancers (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-022-00580-7","article-title":"Germline testing and genetic counselling in prostate cancer","volume":"19","author":"Russo J","year":"2022","unstructured":"Russo J, Giri VN. Germline testing and genetic counselling in prostate cancer. Nat Rev Urol. 2022, 19:331-43. 10.1038\/s41585-022-00580-7","journal-title":"Nat Rev Urol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_238977","article-title":"The role of BRCA testing in hereditary pancreatic and prostate cancer families","volume":"39","author":"Pilarski R","year":"2019","unstructured":"Pilarski R. The role of BRCA testing in hereditary pancreatic and prostate cancer families. Am Soc Clin Oncol Educ Book. 2019, 39:79-86. 10.1200\/EDBK_238977","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2015-202993","article-title":"Young-age prostate cancer","volume":"68","author":"Hussein S","year":"2015","unstructured":"Hussein S, Satturwar S, Van der Kwast T. Young-age prostate cancer. J Clin Pathol. 2015, 68:511-15. 10.1136\/jclinpath-2015-202993","journal-title":"J Clin Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2014.91","article-title":"Prostate cancer in young men: an important clinical entity","volume":"11","author":"Salinas CA","year":"2014","unstructured":"Salinas CA, Tsodikov A, Ishak-Howard M, Cooney KA. Prostate cancer in young men: an important clinical entity. Nat Rev Urol. 2014, 11:317-23. 10.1038\/nrurol.2014.91","journal-title":"Nat Rev Urol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/272824-chest-pain-as-a-symptom-of-early-onset-metastatic-prostate-cancer-exploring-the-role-of-screening","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T20:49:35Z","timestamp":1738097375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/272824-chest-pain-as-a-symptom-of-early-onset-metastatic-prostate-cancer-exploring-the-role-of-screening"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.78143","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,28]]}}}